Continuous Versus Intermittent Infusion of Furosemide in Acute Decompensated Heart Failure

Journal of Cardiac Failure

Volumn 16, Issue 3, 2010, Pages 188-193

  Thomson, Margaret R ^a   Nappi, Jean M ^b,e   Dunn, Steven P ^c   Hollis, Ian B ^d   Rodgers, Jo E ^d   Van Bakel, Adrian B ^e  

^a Baptist Hospital Nashville   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Diuretics; furosemide; heart failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDRALAZINE; INOTROPIC AGENT; NESIRITIDE; NITRIC ACID DERIVATIVE; THIAZIDE DIURETIC AGENT;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG INTERMITTENT THERAPY; DRUG SAFETY; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PARALLEL DESIGN; PILOT STUDY; PRIORITY JOURNAL; SIDE EFFECT; URINE VOLUME; WEIGHT REDUCTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; FUROSEMIDE; HEART FAILURE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77549083836     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.11.005     Document Type: Article

References (16)

1. American Heart Association, American Stroke Association. Heart disease and stroke statistics-2008 update. Available from: http://www.americanheart.org/downloadable/heart/1200078608862HS_Stats%202008.final.pdf. Accessed December 11, 2009.
2. Fonarow G.C. Acute Decompensated Heart Failure National Registry (ADHERE) Advisory Committee. The acute decompensated heart failure national registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 4 Suppl 7 (2003) S21-S30
3. Domanski M., Norman J., Pitt B., Haigney M., Hanlon S., and Peyster E. Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 42 (2003) 705-708
4. Heart Failure Society of America. Evaluation and management of patients with acute decompensated heart failure. J Card Fail 12 (2006) e86-103
5. Copeland J.G., Campbell D.W., Rlachetka J.R., Salomon N.W., and Larson D.F. Diuresis with continuous infusion of furosemide after cardiac surgery. Am J Surg 146 (1983) 796-799
6. Gulbis B.E., and Spencer A.P. Efficacy and safety of a furosemide continuous infusion following cardiac surgery. Ann Pharmacother 40 (2006) 1797-1803
7. Dormans T.P., VanMeyel J.J., Gerlag P.G., Tan Y., Russel F.G., and Smiths P. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 28 (1996) 376-382
8. Salvador DRK, Rey NR, Ramos GC, Punzalan FER. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003178. DOI: 10.1002/14651858.CD003178.pub3
9. Felker G.M., O'Connor C.M., Braunwald E., and for the Heart Failure Clinical Research Network Investigators. Loop diuretics in acute decompensated heart failure, necessary? evil?, a necessary evil?. Circ Heart Fail 2 (2009) 56-62
10. Ellison D.H. Diuretic therapy and resistance in congestive heart failure. Cardiology 96 (2001) 132-143
11. Hammarlund M.M., Odlind B., and Paalzow L.K. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther 233 (1985) 447-453
12. Loon N.R., Wilcox C.S., and Unwin R.J. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Intl 36 (1989) 682-689
13. Lahav M., Regev A., Ra'anani P., and Theodor E. Intermittent administration of furosemide versus continuous infusion preceded by a loading dose for congestive heart failure. Chest 102 (1992) 725-731
14. Pivac N., Rumboldt Z., Sardelic S., Bagatin J., Polic S., Ljutic D., et al. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. Int J Clin Pharm Res (1998) 121-128 XVIII
15. Kramer W.G., Smith W.B., Ferguson J., Serpas T., Grant III A.G., Black P.K., et al. Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion with congestive heart failure. J Clin Pharm 36 (1996) 265-270
16. Aaser E., Gullestad L., Tollofsrud S., Lundberg J., Hall C., Djoseland O., et al. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. Scand J Clin Lab Invest 57 (1997) 361-368